The Patent Finder

Aprea Therapeutics AB

Also on record
Records under this name other than the patents Aprea Therapeutics AB holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.

Showing 1 to 4 of 4 · Back to Aprea Therapeutics AB

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,759,361Azabicyclooctan-3-one derivatives and use thereof
Term ended
Term ended Jun 2, 2025 · USPTO record
Term endedTerm ended Jun 2, 2025USPTO record
US 7,659,278Use of low molecular weight compounds for preparing a medicament useful in treating mutant p53 mediated diseases
Term ended
Term ended May 18, 2024 · USPTO record
Term endedTerm ended May 18, 2024USPTO record
US 7,348,3301-azabicyclo [2,2,2] octan-3-one derivatives
Term ended
Term ended Mar 31, 2022 · USPTO record
Term endedTerm ended Mar 31, 2022USPTO record
US 6,921,7651-Azabicyclo[2.2.2]octan-3-one derivatives and maleimide derivatives and their use for treating cancer tumors
Term ended
Term ended Dec 30, 2021 · USPTO record
Term endedTerm ended Dec 30, 2021USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited